The different patterns of blood pressure elevation by rofecoxib and nabumetone-Reference-Cited by-同舟云学术

The different patterns of blood pressure elevation by rofecoxib and nabumetone

Published:2002-06 Issue:6 Volume:16 Page:431-434
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Reitblat T,Zamir D,Estis L,Priluk R,Drogenikov T,Viskoper J R

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001411.pdf

Reference20 articles.

1. Aalykke C, Lauritsen K . Epidemiology of NSAID-related gastroduodenal mucosal injury Best Pract Res Clin Gastroenterol 2001; 15: 705–722

2. Brooks P et al. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 Rheumatology 1999; 38: 779–788

3. Fitzberald GA, Patrono C . The Coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 2001; 345: 433–442

4. Bayle EA, Freeman PC . Nabumetone (BRL 147777),4-(6-methoxy-2-naphtyl-butan-2-one): a new antiinflammatory agent J Pharm Pharmacol 1982; 34: 562–569

5. Creb WH . Endoscopic studies of nabumetone (Relifex) inpatients with rheumatoid arthritis: a comparative endoscopic and histologic evaluation Am J Med 1987; 83 (Suppl 4B): 19–24

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of injectable collagen in osteoarthritis in multimorbid patients;Clinical Medicine and Pharmacology;2022-11-25

2. Problems of cardiovascular comorbidity in patients with osteoarthritis;Clinical Medicine and Pharmacology;2021-06-17

3. Acoustic cavitation assisted hot melt mixing technique for solid lipid nanoparticles formulation, characterization, and controlled delivery of poorly water soluble drugs;Journal of Drug Delivery Science and Technology;2019-12

4. Theoretical Study of the Phototoxicity of Naproxen and the Active Form of Nabumetone;The Journal of Physical Chemistry A;2008-10-04

5. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation;Health Technology Assessment;2008-04